A Study of RGX-202-01 (Ompenaclid) as Combination Therapy in RAS Mutant Advanced Colorectal Cancer

Clinical trial NCT03597581 · COMPLETED

Trial details

NCT number: NCT03597581
Sponsor: Inspirna, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Gastrointestinal Cancer Gastrointestinal Neoplasms Colorectal Cancer Colorectal Neoplasms Colorectal Carcinoma Gastric Cancer Gastric Neoplasm KRAS Mutation-Related Tumors CRC Colorectal Cancer Metastatic

Start date: 2018-06-05
Primary completion: 2025-03-31
Enrollment: 89

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.